We are live on ! Find out more
TECH icon

Bio-Techne

511 hedge funds and large institutions have $16.4B invested in Bio-Techne in 2021 Q2 according to their latest regulatory filings, with 84 funds opening new positions, 160 increasing their positions, 173 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

110% more first-time investments, than exits

New positions opened: 84 | Existing positions closed: 40

18% more capital invested

Capital invested by funds: $13.9B → $16.4B (+$2.5B)

9% more funds holding

Funds holding: 470511 (+41)

0.96% less ownership

Funds ownership: 377.47%376.51% (-0.96%)

8% less repeat investments, than reductions

Existing positions increased: 160 | Existing positions reduced: 173

19% less funds holding in top 10

Funds holding in top 10: 1613 (-3)

54% less call options, than puts

Call options by funds: $53.9M | Put options by funds: $118M

Holders
511
Holders Change
+41
Holders Change %
+8.72%
% of All Funds
8.89%
Holding in Top 10
13
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-18.75%
% of All Funds
0.23%
New
84
Increased
160
Reduced
173
Closed
40
Calls
$53.9M
Puts
$118M
Net Calls
-$64.4M
Net Calls Change
-$69.2M
Name Holding Trade Value Shares
Change
Change in
Stake
AAP
376
Arax Advisory Partners
Colorado
$353K +$331K +3,140 New
CCIA
377
Campbell & Co Investment Adviser
Maryland
$352K +$329K +3,124 New
AP
378
Advisor Partners
California
$349K +$7.16K +68 +2%
CIM
379
Contravisory Investment Management
Massachusetts
$344K
WAM
380
Wolverine Asset Management
Illinois
$343K +$322K +3,056 New
SP
381
Symmetry Partners
Connecticut
$342K
TSS
382
Two Sigma Securities
New York
$340K +$4.21K +40 +1%
FNBOO
383
First National Bank of Omaha
Nebraska
$337K
MFW
384
Meristem Family Wealth
Minnesota
$334K
BCM
385
Bayesian Capital Management
New York
$333K +$16.4K +156 +6%
GT
386
Greenleaf Trust
Michigan
$326K +$14.3K +136 +5%
IAN
387
Integrated Advisors Network
Texas
$322K -$67.4K -640 -18%
MPCG
388
Matrix Private Capital Group
New York
$321K
AMIM
389
Aull & Monroe Investment Management
Alabama
$315K
SAM
390
Silvercrest Asset Management
New York
$308K -$109K -1,032 -27%
CA
391
Cetera Advisors
Colorado
$303K
MAM
392
Martingale Asset Management
Massachusetts
$294K -$1.37M -12,984 -83%
Creative Planning
393
Creative Planning
Kansas
$285K -$197K -1,868 -42%
QI
394
QS Investors
New York
$285K -$84.2K -800 -24%
WPC
395
White Pine Capital
Minnesota
$282K
PCP
396
Proficio Capital Partners
Massachusetts
$279K +$1.68K +16 +0.7%
PA
397
Parallel Advisors
California
$275K +$18.1K +172 +8%
EIP
398
Ellis Investment Partners
Pennsylvania
$271K
SWA
399
SFMG Wealth Advisors
Texas
$270K
PA
400
Procyon Advisors
Connecticut
$264K

TECH Hedge Fund Activity: Q2 2021 in Review

511 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q2 2021, worth a combined $16.4B — up 18% from $13.9B a quarter earlier.

Buyers outnumbered sellers: 84 funds opened new TECH positions and 40 closed out — a net gain of 44 holders — while 160 added to existing stakes and 173 trimmed.

The largest buyer was BlackRock, adding an estimated $275M. The largest seller was Brown Capital Management, cutting an estimated $108M.

  • 511 institutional investors held Bio-Techne (TECH) as of Q2 2021, up from 470 in Q1 2021.
  • Funds reported $16.4B of Bio-Techne stock for Q2 2021, up 18% quarter-over-quarter.
  • 84 funds opened new Bio-Techne positions in Q2 2021 and 40 closed out, a net change of +44 holders.
  • The largest Bio-Techne buyer in Q2 2021 was BlackRock, an estimated $275M added.
  • The largest Bio-Techne seller in Q2 2021 was Brown Capital Management, an estimated $108M sold.

Based on aggregated 13F filings for Q2 2021.